The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

Despite over 100 years of insulin therapy, glycemia remains suboptimal for many individuals
living with diabetes. Data from international diabetes registries highlight that most youth with …

In the last few years, machine learning (ML) and artificial intelligence have seen a new wave
of publicity fueled by the huge and ever‐increasing amount of data and computational …

Background: The t: slim X2™ insulin pump with Control-IQ® technology from Tandem
Diabetes Care is an advanced hybrid closed-loop system that was first commercialized in …

Background Closed-loop systems that automate insulin delivery may improve glycemic
outcomes in patients with type 1 diabetes. Methods In this 6-month randomized, multicenter …

Advances in diabetes technologies have enabled the development of automated closed-
loop insulin delivery systems. Several hybrid closed-loop systems have been …

Technological advances have had a major effect on the management of type 1 diabetes. In
addition to blood glucose meters, devices used by people with type 1 diabetes include …

The year 2021 will mark 100 years since the discovery of insulin. Insulin, the first medication
to be discovered for diabetes, is still the safest and most potent glucose-lowering therapy …

Introduction Several different forms of automated insulin delivery systems (AID systems)
have recently been developed and are now licensed for type 1 diabetes (T1D). We …

Diabetes technologies represent a paradigm shift in type 1 diabetes care. Continuous
subcutaneous insulin infusion (CSII) pumps and continuous glucose monitors (CGM) …